Search Results 2251-2260 of 13642 for monoclonal antibody

1. Clonal hematopoiesis clinic stratifies risk for patients with cancer

   The concept of early detection of pre-malignant states has been around for several years and was first defined as monoclonal gammopathy of undetermined ...

2. Clinical trials - Oncology (Medical)

   ... antibody) * Olaparib (a type of PARP inhibitor). Comparison Of In-Home Versus In-Clinic Administration Of Subcutaneous Nivolumab Through Cancer CARE ...

3. Clinical trials - Oncology (Medical)

   ... antibody) * Olaparib (a type of PARP inhibitor). Comparison Of In-Home Versus In-Clinic Administration Of Subcutaneous Nivolumab Through Cancer CARE ...

4. AZD0120 In Relapsed/Refractory Multiple Myeloma (DURGA-1) - Mayo Clinic

   ... antibody. * Have documented evidence of progressive disease per IMWG criteria. * Participant must have measurable disease at screening. * Participant must ...

5. Onvansertib For The Treatment Of Recurrent Or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

   NOTE: Patients with antibody to hepatitis B core antibody are eligible if they have no measurable viral titer. Patients who have had a hepatitis B virus ...

6. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Mayo Clinic

   ... antibodies or anti-MOG antibodies) 20. Diagnosis of progressive multifocal leukoencephalopathy (PML) Exclusion Criteria Specific to PD Subjects: 21 ...

7. Clinical trials - Oncology (Medical)

   This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

8. A Study To Estimate The Clinical Benefit Of REGN2810 For Patients With Advanced Squamous Cell Skin Cancer

   Allergic reactions or acute hypersensitivity reaction attributed to antibody treatments; Known allergy to doxycycline or tetracycline; Patients with a history ...

9. A Study To Evaluate Radiation- And Alkylator-free Bone Marrow Transplantation Regimen For Patients With Dyskeratosis Congenita - Mayo Clinic

   Positive patient anti-donor HLA antibody, which is deemed clinically significant. Prior allogeneic marrow or stem cell transplantation. Prior solid organ ...

10. A Study Of The Safety And Effectiveness Of Atezolizumab Combined With Etoposide, And Carboplatin For Patients With Untreated Extensive-Stage Small Cell Lung Cancer - Mayo Clinic

    Prior treatment with cluster of differentiation 137 (CD137) agonists or immune checkpoint blockade therapies, anti-PD1, and anti-PD-L1 therapeutic antibody ...